Skip to main content
logo
Regentis Biomaterials Ltd. (RGNT)
NYSEAMERICAN: RGNT · Real-Time Price · USD
3.790
+0.150 (4.12%)
At close: Jul 10, 2026, 4:00 PM EDT
3.740
-0.050 (-1.32%)
After-hours: Jul 10, 2026, 5:13 PM EDT

Regentis Biomaterials Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.250.25----
Net Debt / Equity Ratio
-1.30-1.30----
Net Debt / EBITDA Ratio
0.890.89----
Net Debt / FCF Ratio
4.504.50----
Quick Ratio
2.572.57----
Current Ratio
2.652.65----
Return on Equity (ROE)
-575.38%-575.38%----
Return on Assets (ROA)
-182.94%-182.94%----
Return on Invested Capital (ROIC)
-1164.24%-1164.24%----
Return on Capital Employed (ROCE)
-293.76%-293.76%----
Buyback Yield / Dilution
-249.41%0.00%-226.64%-6.97%0.00%0.00%
Total Shareholder Return
-249.41%0.00%-226.64%-6.97%0.00%0.00%
SEC Filings: 10-K · 10-Q